Citius Pharmaceuticals, Inc. (CTXR) › Operating IncomeCitius Pharmaceuticals, Inc. (CTXR) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$25.6K2012: -$1.02M2013: -$1.18M2014: -$653.8K2015: -$3.23M2016: -$7.45M2017: -$9.99M2018: -$13.79M2019: -$15.60M2020: -$17.71M2021: -$23.53M2022: -$33.32M2023: -$36.73M2024: -$42.00M2025: -$38.53M-$38.53M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$38.53M+8.3%2024-$42.00M-14.3%2023-$36.73M-10.3%2022-$33.32M-41.6%2021-$23.53M-32.9%2020-$17.71M-13.5%2019-$15.60M-13.1%2018-$13.79M-38.1%2017-$9.99M-34.1%2016-$7.45M-130.6%2015-$3.23M-394.0%2014-$653.8K+44.7%2013-$1.18M-16.4%2012-$1.02M-3863.5%2011-$25.6K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share